Pharco Pharmaceuticals is conducting Phase 3 clinical trial on the combination of ravidasvir and sofosbuvir to treat patients with genotype-4 chronic hepatitis C virus. The company operates a facility for manufacturing both sterile and non-sterile Penicillins in Egypt. It has scientific offices in KSA, Yemen, the UAE, Libya, Bahrain, Lebanon, and Romania. Pharco Pharmaceuticals is headquartered in Amriya, Alexandria, Egypt. Еще
